A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: blood loss (228), haemorrhage (88), flow (240)

AAA screening leaflet - Public Health England

Description
Chest Heart Aorta with an aneurysm Abdomen Abdominal aortic aneurysm (AAA) screening A free NHS check for men aged 65 and
Url
/Media/UHS-website-2019/Docs/Services/Blood-heart-and-circulation/AAA-screening-leaflet-Public-Health-England.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (accelerated) Indication • Neoadjuvant / adjuvant therapy of early breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

ClofarabineCytarabine

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA ALL CLOFARABINE-CYTARABINE In-Patient Regimen Clofarabine not licensed in adult patients. This may require funding
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/ClofarabineCytarabine.pdf

Brachytherapy vault treatment - patient information

Description
This factsheet explains what brachytherapy vault treatment is and what to expect during treatment.
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Brachytherapy-vault-treatment-1314-PIL.pdf

Tracheostomy - patient information

Description
This factsheet explains what a tracheostomy is, what the procedure involves and what the possible risks are.
Url
/Media/UHS-website-2019/Patientinformation/Ear-nose-and-throat/Tracheostomy-2851-PIL.pdf

Selective internal radiation therapy (SIRT) - patient information

Description
This factsheet explains what selective internal radiation therapy (SIRT) is, what the cancer treatment involves, and what the possible benefits and
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Selective-internal-radiation-therapy-SIRT-3094-PIL.pdf

Docetaxel-Nintedanib v1

Description
Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastatic NSCLC of adenocarcinoma origin that has progressed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf

Docetaxel

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DOCETAXEL (75) Regimen NSCLC – Docetaxel (75) Indication Second line therapy of stage IIIB
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxelver12.pdf

Cisplatin and Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMETREXED Regimen NSCLC – Cisplatin-Pemetrexed Indication First line therapy of stage III
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandPemetrexedver12.pdf

MesoCisPemVer1.3

Description
Chemotherapy Protocol MESOTHELIOMA CISPLATIN-PEMETREXED Regimen Mesothelioma – Cisplatin-Pemetrexed Indication First line therapy of advanced pleural mesothelioma where the disease is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/MesoCisPemVer1.3.pdf
421 to 430 of 706
Previous … 41 42 43 44 45 … Next